These findings suggest that the clinical benefits of proton pump inhibitors use against the excess risks of cardiovascular events and mortality should be taken into consideration among patients with type 2 diabetes.
These findings suggest that the clinical benefits of proton pump inhibitors use against the excess risks of cardiovascular events and mortality should be taken into consideration among patients with type 2 diabetes.
Worrisome